Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan and simvastatin for high blood pressure and high cholesterol
NCT00385931Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2002
- Primary completion
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN), hypercholesterolemia and dyslipidemia comparing Valsartan Monotherapy with Valsartan + Simvastatin Combination (2 arms). Primary endpoint: Change from baseline in ambulatory systolic blood pressure at 12 weeks. Started Jan 2002; status: completed.
02
Drugs
valsartansimvastatin
03
Conditions
hypertension (HTN)hypercholesterolemiadyslipidemia
Beyond the preview
Go deeper on NCT00385931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385931.